Michael J. Foster
Known title: DirectorCIK: 0001145246
Associated companies
Transaction History
| SBRA | ▲ Buy | Grant | 791 | $0 | 8/31/2026 | View on chart |
| SBRA | ▲ Buy | Grant | 8,310 | $0 | 6/17/2026 | View on chart |
| SBRA | ▲ Buy | Grant | 817 | $0 | 5/29/2026 | View on chart |
| SBRA | ▼ Sell | Gift | 500 | $0 | 5/29/2026 | View on chart |
| SBRA | ▼ Sell | Gift | 490 | $0 | 5/27/2026 | View on chart |
| SBRA | ▼ Sell | Gift | 813 | $0 | 5/22/2026 | View on chart |
| SBRA | ▲ Buy | Grant | 781 | $0 | 2/27/2026 | View on chart |
| SBRA | ▲ Buy | Grant | 808 | $0 | 11/28/2025 | View on chart |
| SBRA | ▲ Buy | Grant | 813 | $0 | 8/29/2025 | View on chart |
| SBRA | ▼ Sell | Gift | 750 | $0 | 8/19/2025 | View on chart |
| SBRA | ▼ Sell | Gift | 750 | $0 | 6/26/2025 | View on chart |
| SBRA | ▲ Buy | Grant | 8,178 | $0 | 6/12/2025 | View on chart |
| SBRA | ▲ Buy | Grant | 914 | $0 | 5/30/2025 | View on chart |
| SBRA | ▼ Sell | Open Market | 11,000 | $200K | 5/20/2025 | View on chart |
| SBRA | ▲ Buy | Grant | 946 | $0 | 2/28/2025 | View on chart |
| SBRA | ▲ Buy | Grant | 826 | $0 | 11/29/2024 | View on chart |
| SBRA | ▼ Sell | Gift | 1,350 | $0 | 9/17/2024 | View on chart |
| SBRA | ▲ Buy | Grant | 889 | $0 | 8/30/2024 | View on chart |
| SBRA | ▲ Buy | Grant | 9,480 | $0 | 6/13/2024 | View on chart |
| SBRA | ▲ Buy | Grant | 1,011 | $0 | 5/31/2024 | View on chart |
| SBRA | ▼ Sell | Open Market | 10,000 | $147K | 5/14/2024 | View on chart |
| SBRA | ▲ Buy | Grant | 1,040 | $0 | 2/29/2024 | View on chart |
| SBRA | ▲ Buy | Grant | 967 | $0 | 11/30/2023 | View on chart |
| SBRA | ▲ Buy | Grant | 1,101 | $0 | 8/31/2023 | View on chart |
| SBRA | ▲ Buy | Grant | 11,382 | $0 | 6/14/2023 | View on chart |
| SBRA | ▲ Buy | Grant | 1,092 | $0 | 5/31/2023 | View on chart |
| SBRA | ▲ Buy | Grant | 1,010 | $0 | 2/28/2023 | View on chart |
| SBRA | ▲ Buy | Grant | 909 | $0 | 11/30/2022 | View on chart |
| SBRA | ▼ Sell | Gift | 2,600 | $0 | 9/15/2022 | View on chart |
| SBRA | ▲ Buy | Grant | 768 | $0 | 8/31/2022 | View on chart |
| SBRA | ▲ Buy | Grant | 8,751 | $0 | 6/14/2022 | View on chart |
| SBRA | ▲ Buy | Grant | 759 | $0 | 5/31/2022 | View on chart |
| SBRA | ▲ Buy | Grant | 776 | $0 | 2/28/2022 | View on chart |
| SBRA | ▲ Buy | Grant | 785 | $0 | 11/30/2021 | View on chart |
| SBRA | ▲ Buy | Grant | 624 | $0 | 8/31/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Sabra Health Care REIT analysts lower price targets
UBS kept a neutral rating on Sabra Health Care REIT but reduced its price target to $20. Barclays also maintained an equal‑weight stance while cutting its target to $21. Both revisions suggest a more modest outlook for the REIT. The new targets sit near the stock’s recent support level around $19.70.
Sabra Health Care REIT analysts lower price targets. UBS kept a neutral rating on Sabra Health Care REIT but reduced its price target to $20. Barclays also maintained an equal‑weight stance while cutting its target to $21. Both revisions suggest a more modest outlook for the REIT. The new targets sit near the stock’s recent support level around $19.70.